nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0773	0.0845	CcSEcCtD
Terazosin—Gout—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0244	CcSEcCtD
Terazosin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0232	CcSEcCtD
Terazosin—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0211	0.023	CcSEcCtD
Terazosin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0188	CcSEcCtD
Terazosin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0181	CcSEcCtD
Terazosin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0178	CcSEcCtD
Terazosin—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0174	CcSEcCtD
Terazosin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0155	0.017	CcSEcCtD
Terazosin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0165	CcSEcCtD
Terazosin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.015	0.0164	CcSEcCtD
Terazosin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0163	CcSEcCtD
Terazosin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0146	0.016	CcSEcCtD
Terazosin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0151	CcSEcCtD
Terazosin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0137	0.015	CcSEcCtD
Terazosin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0146	CcSEcCtD
Terazosin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0143	CcSEcCtD
Terazosin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0139	CcSEcCtD
Terazosin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0134	CcSEcCtD
Terazosin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0132	CcSEcCtD
Terazosin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.012	0.0132	CcSEcCtD
Terazosin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0119	0.013	CcSEcCtD
Terazosin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0119	0.013	CcSEcCtD
Terazosin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0124	CcSEcCtD
Terazosin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0124	CcSEcCtD
Terazosin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0124	CcSEcCtD
Terazosin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0122	CcSEcCtD
Terazosin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.011	0.012	CcSEcCtD
Terazosin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0119	CcSEcCtD
Terazosin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0115	CcSEcCtD
Terazosin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0113	CcSEcCtD
Terazosin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0113	CcSEcCtD
Terazosin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0101	0.011	CcSEcCtD
Terazosin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00974	0.0107	CcSEcCtD
Terazosin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00933	0.0102	CcSEcCtD
Terazosin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00896	0.0098	CcSEcCtD
Terazosin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00893	0.00976	CcSEcCtD
Terazosin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00891	0.00974	CcSEcCtD
Terazosin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00883	0.00966	CcSEcCtD
Terazosin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0088	0.00962	CcSEcCtD
Terazosin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00857	0.00938	CcSEcCtD
Terazosin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00852	0.00932	CcSEcCtD
Terazosin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00844	0.00923	CcSEcCtD
Terazosin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00831	0.00909	CcSEcCtD
Terazosin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0082	0.00897	CcSEcCtD
Terazosin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00817	0.00894	CcSEcCtD
Terazosin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00816	0.00892	CcSEcCtD
Terazosin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00804	0.00879	CcSEcCtD
Terazosin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.008	0.00874	CcSEcCtD
Terazosin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00794	0.00868	CcSEcCtD
Terazosin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00774	0.00847	CcSEcCtD
Terazosin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00774	0.00847	CcSEcCtD
Terazosin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00774	0.00847	CcSEcCtD
Terazosin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00772	0.00844	CcSEcCtD
Terazosin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00765	0.00837	CcSEcCtD
Terazosin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00757	0.00828	CcSEcCtD
Terazosin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00749	0.00819	CcSEcCtD
Terazosin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00742	0.00812	CcSEcCtD
Terazosin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00742	0.00812	CcSEcCtD
Terazosin—Shock—Hydrochlorothiazide—nephrolithiasis	0.0073	0.00799	CcSEcCtD
Terazosin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00795	CcSEcCtD
Terazosin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00793	CcSEcCtD
Terazosin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00785	CcSEcCtD
Terazosin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00708	0.00774	CcSEcCtD
Terazosin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00694	0.00759	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00676	0.0074	CcSEcCtD
Terazosin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00671	0.00734	CcSEcCtD
Terazosin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00667	0.00729	CcSEcCtD
Terazosin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00662	0.00724	CcSEcCtD
Terazosin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0066	0.00722	CcSEcCtD
Terazosin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00715	CcSEcCtD
Terazosin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00645	0.00706	CcSEcCtD
Terazosin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0064	0.007	CcSEcCtD
Terazosin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00635	0.00694	CcSEcCtD
Terazosin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00635	0.00694	CcSEcCtD
Terazosin—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.00623	0.1	CbGpPWpGaD
Terazosin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00612	0.00669	CcSEcCtD
Terazosin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00607	0.00664	CcSEcCtD
Terazosin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00642	CcSEcCtD
Terazosin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00642	CcSEcCtD
Terazosin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00598	CcSEcCtD
Terazosin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00583	CcSEcCtD
Terazosin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00575	CcSEcCtD
Terazosin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00508	0.00556	CcSEcCtD
Terazosin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00537	CcSEcCtD
Terazosin—KCNH6—nephron tubule—nephrolithiasis	0.00482	0.206	CbGeAlD
Terazosin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00472	0.00516	CcSEcCtD
Terazosin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00512	CcSEcCtD
Terazosin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00512	CcSEcCtD
Terazosin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00509	CcSEcCtD
Terazosin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00482	CcSEcCtD
Terazosin—KCNH6—renal system—nephrolithiasis	0.00438	0.187	CbGeAlD
Terazosin—KCNH6—kidney—nephrolithiasis	0.00424	0.181	CbGeAlD
Terazosin—ADRA1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00351	0.0563	CbGpPWpGaD
Terazosin—ADRA1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00295	0.0473	CbGpPWpGaD
Terazosin—ADRA1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00291	0.0467	CbGpPWpGaD
Terazosin—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00259	0.0415	CbGpPWpGaD
Terazosin—ADRA1B—renal system—nephrolithiasis	0.00248	0.106	CbGeAlD
Terazosin—ADRA1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00245	0.0393	CbGpPWpGaD
Terazosin—ADRA1B—kidney—nephrolithiasis	0.0024	0.102	CbGeAlD
Terazosin—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00217	0.0349	CbGpPWpGaD
Terazosin—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00215	0.0345	CbGpPWpGaD
Terazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00179	0.0287	CbGpPWpGaD
Terazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00159	0.0255	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Other—CHRM3—nephrolithiasis	0.00156	0.025	CbGpPWpGaD
Terazosin—ADRA1A—renal system—nephrolithiasis	0.00139	0.0595	CbGeAlD
Terazosin—KCNH2—renal system—nephrolithiasis	0.00135	0.0575	CbGeAlD
Terazosin—ADRA1D—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00121	0.0194	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00108	0.0174	CbGpPWpGaD
Terazosin—ADRA1D—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00105	0.0169	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00101	0.0161	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0009	0.0144	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000893	0.0143	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000876	0.0141	CbGpPWpGaD
Terazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000872	0.014	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000799	0.0128	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000784	0.0126	CbGpPWpGaD
Terazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000775	0.0124	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000727	0.0117	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000677	0.0109	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00065	0.0104	CbGpPWpGaD
Terazosin—ABCB1—nephron tubule—nephrolithiasis	0.00065	0.0277	CbGeAlD
Terazosin—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000646	0.0104	CbGpPWpGaD
Terazosin—ABCB1—renal system—nephrolithiasis	0.000591	0.0252	CbGeAlD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00058	0.00931	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000578	0.00927	CbGpPWpGaD
Terazosin—ABCB1—kidney—nephrolithiasis	0.000571	0.0244	CbGeAlD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000562	0.00902	CbGpPWpGaD
Terazosin—ABCB1—cortex of kidney—nephrolithiasis	0.000556	0.0237	CbGeAlD
Terazosin—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.000511	0.00821	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000499	0.00801	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000482	0.00773	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.000464	0.00745	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.000442	0.00709	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000438	0.00702	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000438	0.00702	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000428	0.00686	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000424	0.00681	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.000404	0.00649	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00039	0.00626	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.000385	0.00618	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000377	0.00605	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000367	0.00589	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000357	0.00573	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000357	0.00573	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000345	0.00554	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000342	0.00549	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.000335	0.00538	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000326	0.00523	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000323	0.00518	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000314	0.00503	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000298	0.00478	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000287	0.0046	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.000274	0.0044	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00027	0.00434	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00027	0.00434	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000268	0.0043	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00026	0.00418	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000255	0.00409	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000251	0.00403	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000251	0.00403	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00025	0.00401	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000238	0.00382	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000231	0.00371	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000228	0.00366	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000228	0.00365	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000227	0.00364	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000224	0.0036	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000224	0.0036	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.000207	0.00333	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000207	0.00333	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000202	0.00324	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.00019	0.00304	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000188	0.00302	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000185	0.00297	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.000185	0.00297	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000184	0.00295	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000179	0.00287	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000172	0.00276	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000168	0.0027	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000167	0.00268	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000155	0.00249	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000154	0.00247	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000154	0.00247	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000153	0.00245	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000138	0.00222	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000137	0.00219	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000137	0.00219	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000134	0.00215	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.000123	0.00197	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000118	0.00189	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000118	0.00189	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000111	0.00178	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000102	0.00163	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	9.87e-05	0.00158	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	9.03e-05	0.00145	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AQP1—nephrolithiasis	8.39e-05	0.00135	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.59e-05	0.00122	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	6.15e-05	0.000987	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	5.1e-05	0.000819	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	4.53e-05	0.000728	CbGpPWpGaD
